Adams1002 Profile Banner
Adam Steinlauf Profile
Adam Steinlauf

@Adams1002

Followers
615
Following
528
Media
151
Statuses
714

I am a specialist in the Inflammatory Bowel Diseases (IBD), Ulcerative Coltitis and Crohn's Disease @ Mount Sinai

New York City
Joined August 2010
Don't wanna be here? Send us removal request.
@Adams1002
Adam Steinlauf
10 months
Had a great time practicing with Tom Ullman for our reunion performance at this years CCF Gala.
Tweet media one
0
1
12
@Adams1002
Adam Steinlauf
1 year
Our paper on the beneficial effects of upadacitinib on quality of life in patients with Crohn’s Disease.
Tweet media one
0
2
15
@Adams1002
Adam Steinlauf
1 year
Tweet media one
0
0
0
@Adams1002
Adam Steinlauf
1 year
Tweet media one
0
0
3
@Adams1002
Adam Steinlauf
1 year
Great evening with colleagues and fellows!!.
@MSH_GI_Fellows
Mount Sinai Hospital GI Fellowship Program
1 year
Springtime at @MountSinaiGI means another round of Faculty Dining Series! (No bowel prep required.) . @Danny_WongMD @Typical_Brian @RababOun @HyderSaidMD @Adams1002 @ManasiAgrawalMD @brownbrij76 @jdclaytor @SalamBeahMD @JellyanaPeraza
Tweet media one
Tweet media two
Tweet media three
1
0
5
@Adams1002
Adam Steinlauf
1 year
Tweet media one
0
0
3
@Adams1002
Adam Steinlauf
1 year
Proud to be promoted to Professor of Medicine at Icahn School of Medicine, Mount Sinai Health System.
8
2
39
@Adams1002
Adam Steinlauf
2 years
Our article on biosimilars for the ACG FDA-Related Matters Committee.
@AmJGastro
AJG - The American Journal of Gastroenterology
2 years
In the 📕#RedJournal:. Overview of Biosimilars in Inflammatory Bowel Diseases.Feagins, et al. 👉 @GimdGold @Adams1002
Tweet media one
0
4
6
@Adams1002
Adam Steinlauf
2 years
RT @AmJGastro: In the 📕#RedJournal:. Overview of Biosimilars in Inflammatory Bowel Diseases.Feagins, et al. 👉 @Gi….
0
7
0
@Adams1002
Adam Steinlauf
2 years
RT @MSHS_IBDCenter: If you suffer from IBD and your disease is difficult to control, or if you simply want to be involved in research that….
0
2
0
@Adams1002
Adam Steinlauf
2 years
RT @MSHS_IBDCenter: Are you interested in participating in a clinical trial for Inflammatory Bowel Disease? If so, please fill out the foll….
0
2
0
@Adams1002
Adam Steinlauf
2 years
So great to see everyone at the CCF Gala.
Tweet media one
0
1
12
@Adams1002
Adam Steinlauf
2 years
RT @IcahnMountSinai: Dr. Marla Dubinsky discusses a study that showed the efficacy of Mirikizumab in patients with ulcerative colitis, high….
0
4
0
@Adams1002
Adam Steinlauf
2 years
RT @DOMSinaiNYC: Congratulations to Adam Steinlauf, MD, for receiving the prestigious 2023 Rosenthal Humanitarian of the Year Award from th….
0
2
0
@Adams1002
Adam Steinlauf
2 years
I’m excited to be this years Crohn’s & Colitis Foundation Rosenthal Humanitarian Award recipient. Please join me in supporting this important organization!!.
1
2
5
@Adams1002
Adam Steinlauf
2 years
Our review article for the @AmCollegeGastro FDA-related Matters Committee. Overview of biosimilars in inflammatory bowel diseases : Official journal of the American College of Gastroenterology | ACG
0
5
18
@Adams1002
Adam Steinlauf
2 years
The CCF is committed to supporting patients and families who suffer from IBD and finding a cure for these diseases. Please join me as this years Humanitarian Award recipient in supporting this great organization.
0
1
6
@Adams1002
Adam Steinlauf
2 years
Dr. Maia Kayal @MaiaKayalMD presents the spectrum of pouchitis at our IBD retreat.
Tweet media one
0
3
6
@Adams1002
Adam Steinlauf
2 years
RT @MountSinaiGI: As we wrap up a day filled with revealing talks and diverse viewpoints on #IBD, at the center of every discussion was one….
0
2
0
@Adams1002
Adam Steinlauf
2 years
Dr. Ananthakrishnan delivering the annual Lloyd Mayer Lecture.
Tweet media one
0
2
10